Recursion Pharmaceuticals
RXRX
RXRX
126 hedge funds and large institutions have $1.62B invested in Recursion Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 52 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
+42
Holders Change %
+50%
% of All Funds
1.95%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.12%
New
53
Increased
52
Reduced
10
Closed
11
Calls
$2.03M
Puts
$878K
Net Calls
+$1.16M
Net Calls Change
+$101K
Top Buyers
| 1 |
1
BlackRock
New York
|
$116M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$105M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$79.8M |
| 4 |
AI
4
ArchPoint Investors
Coral Gables,
Florida
|
$21.5M |
| 5 |
5
AllianceBernstein
Nashville,
Tennessee
|
$49.3M |
